11
11
Oct 10, 2024
10/24
by
CNBC
tv
eye 11
favorite 0
quote 0
gsk will pay $70 million to settle a related whistleblower lawsuit in connecticut.he firm continues to deny any wrongdoing under the deal. >>> more bad news for german autos, bmw posting a 13% sales plunge in the quarter. mercedes-benz fared better with q3 china sales fell just13% on the year. sales at givaudan rose fell. the giant said it saw growth in all markets. earnings per share is expected to decline 1% on the year after the first positive period since 2022 in the second quarter. analysis from bank of america research shows analysts expect the strongest earnings growth from the basic materials, while financials is the biggest contributor to growth. without the companies, stoxx 600 earnings would be seen 6% lower on the year. energy, tech and utility sectors are seen dragging on the outlook, but the worst performance is expected from the consumer discretionary companies which include european automakers. >>> data from deutsche bank shows downward revision from the auto sector from this quarter over the past three months. profit margin notice s in the se expect
gsk will pay $70 million to settle a related whistleblower lawsuit in connecticut.he firm continues to deny any wrongdoing under the deal. >>> more bad news for german autos, bmw posting a 13% sales plunge in the quarter. mercedes-benz fared better with q3 china sales fell just13% on the year. sales at givaudan rose fell. the giant said it saw growth in all markets. earnings per share is expected to decline 1% on the year after the first positive period since 2022 in the second...
19
19
Oct 9, 2024
10/24
by
CNBC
tv
eye 19
favorite 0
quote 0
state court liability suits which claim that a discounted version of gsk's heartburn drug zantac hadncer. shares of astera labs gained 15% after they produced a new series of fabric switches, a key component of data management in artificial intelligence. now 15%. >>> still ahead, cnbc catching up with jpmorgan's coo daniel pinto. we have highlights just ahead. all over this rally. dow and s&p both as we said on track for a record close. s&p trying to top 5800. we'll watch that next. >>> coming up next, tell you what's dragging boeing shares lower today. what it might signal for the broader aerospace sector as well. check out a new cnbc special, ozempic underworld, the black market ofobesity drugs. watch now cnbc.com/ozempicunderworld. market zone is next. so, my best friend sophie says you've been a huge help. at ameriprise financial, more than 9 out of 10 of our clients are likely to recommend us. our neighbors, the garcía's, love working with you. because the advice we give is personalized, -hey, john reese, jr. -how's your father doing? to help reach your goals with confidence. my
state court liability suits which claim that a discounted version of gsk's heartburn drug zantac hadncer. shares of astera labs gained 15% after they produced a new series of fabric switches, a key component of data management in artificial intelligence. now 15%. >>> still ahead, cnbc catching up with jpmorgan's coo daniel pinto. we have highlights just ahead. all over this rally. dow and s&p both as we said on track for a record close. s&p trying to top 5800. we'll watch that...
0
0.0
Oct 31, 2024
10/24
by
CNBC
tv
eye 0
favorite 0
quote 0
gsk's completely out pfizer's down to 15% as that happened we saw a real shift in our shareholder basestaple shareholders. i think it's the consistent track record of delivery and some of those overhangs that are now gone has really helped unlock the value of the stock. >> on the quarter just reported i saw something thief not seen in a long time, which is a concern to back out of a pound versus a dollar. i think it created some mystery let's call it mystery because people aren't used to seeing anything other than dollar weak dollar strong. it's a little convolute skpid think it may have hurt the perception of how you really did this quarter >> yeah. if you step back on sales growth, organic sales growth, 6.1% 3.1% pricing 2.8% volume. volume growth like that is very important in this particular market and we're sele resilience in our categories. organic operating margin our operating margin was 23% up 30 basis points organically but we had a headwind of 120 basis points and it was due to the pound strengthening to the dollar and other currencies so you know, it's hard to manage to fx
gsk's completely out pfizer's down to 15% as that happened we saw a real shift in our shareholder basestaple shareholders. i think it's the consistent track record of delivery and some of those overhangs that are now gone has really helped unlock the value of the stock. >> on the quarter just reported i saw something thief not seen in a long time, which is a concern to back out of a pound versus a dollar. i think it created some mystery let's call it mystery because people aren't used to...
0
0.0
Oct 30, 2024
10/24
by
CNBC
tv
eye 0
favorite 0
quote 0
. >>> now, gsk lowered its vaccine sales for the second time. amid the rsv and shingles vaccines.fter the giant posted a beat on the third quarter, coming in at 2.75 billion pounds shares at this stage down 2.5%. >> and sandoz actually increased their growth after sales came in at $2.6 billion that's up 12% on the year. driven by the similars. the giant that spun off from its core last year with guidance around 20%. in the retail space, we heard from next, they upgraded their annual profit guidance to more than 1 billion pounds, the first time it's lifted its output in months. and that's to shoppers wrapping up amid cooler temperatures. >> thank you, silvia, you can see the stocks affecting the big movers this morning, the top gainers. the company i'm watching very closely is puig. this company was atop the markets starting at trade. and then reflected the numbers that crossed the third quarter. 11.6% revenue in the third quarter outperforming the premium beauty market, so you're seeing reaction to those numbers in particular, acceleration in fragrances so proving to be somewhat r
. >>> now, gsk lowered its vaccine sales for the second time. amid the rsv and shingles vaccines.fter the giant posted a beat on the third quarter, coming in at 2.75 billion pounds shares at this stage down 2.5%. >> and sandoz actually increased their growth after sales came in at $2.6 billion that's up 12% on the year. driven by the similars. the giant that spun off from its core last year with guidance around 20%. in the retail space, we heard from next, they upgraded their...
27
27
Oct 9, 2024
10/24
by
CNBC
tv
eye 27
favorite 0
quote 0
shares of gsk spiking almost 7% after being briefly halted. company agreed to settle product liability cases for up to $2.2 billion. "the exchange" is back after this. >> this is "the exchange" on cnbc. personalized financial advice from ameriprise can do more than help you reach your goals. i can make this work. it can help you reach them with confidence. no wonder more than 9 out of 10 of our clients are likely to recommend us. ameriprise financial. advice worth talking about. personalized financial advice from ameriprise can do more than help you reach your goals. -you can make this work. -we can make this work. it can help you reach them with confidence. no wonder more than 9 out of 10 of our clients are likely to recommend us. ameriprise financial. advice worth talking about. >>> welcome back. the ten-year is on the move after the auction top of the hour. rick, what do you see? >> you know, it's a very strange auction today. first of all, let's start out at the beginning. talking about 39 million reopened tens, adding to a group of ten-ye
shares of gsk spiking almost 7% after being briefly halted. company agreed to settle product liability cases for up to $2.2 billion. "the exchange" is back after this. >> this is "the exchange" on cnbc. personalized financial advice from ameriprise can do more than help you reach your goals. i can make this work. it can help you reach them with confidence. no wonder more than 9 out of 10 of our clients are likely to recommend us. ameriprise financial. advice worth...
0
0.0
Oct 14, 2024
10/24
by
BBCNEWS
tv
eye 0
favorite 0
quote 0
there is going to be the bosses of gsk, bp, i to be the bosses of gsk, bp, companies like nissan, goldman will also do an in conversation event with the former ceo and chairman of google, eric schmidt. some really big names attending here. one person who has not been invited is elon musk. there's been some commentary around that, a huge, wealthy investor as he is. the government says that it's because he is not currently looking to invest in the uk and if he was opening up anything where there was international competition for it, the uk would very much want to be talking to him. some really big names due to be attending today and the government, the politics of this, wanting to be seen to be talking to these people. in some ways it might be seen as quite unusual for a labour government to be the ones really showing off their pro—business credentials, but that was very much something that was very much something that we saw throughout the general election campaign, very much part of the petro government and it is a really central part of what they see as their plans for growth in the econ
there is going to be the bosses of gsk, bp, i to be the bosses of gsk, bp, companies like nissan, goldman will also do an in conversation event with the former ceo and chairman of google, eric schmidt. some really big names attending here. one person who has not been invited is elon musk. there's been some commentary around that, a huge, wealthy investor as he is. the government says that it's because he is not currently looking to invest in the uk and if he was opening up anything where there...